FDA Approved: ZELSUVMI — Original Application (LNHC, Inc.)

View source ↗

Summary

FDA approved ZELSUVMI (berdazimer) from LNHC, Inc. as an original NDA for the treatment of molluscum contagiosum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Molluscum Contagiosum

Drugs mentioned

• ZELSUVMI (berdazimer)

Snippet

ORIG AP for ZELSUVMI (BERDAZIMER)